Stocks and InvestingStocks and Investing
Wed, September 30, 2020
Tue, September 29, 2020
Mon, September 28, 2020
Sat, September 26, 2020
Fri, September 25, 2020
Thu, September 24, 2020
Wed, September 23, 2020
Tue, September 22, 2020
Mon, September 21, 2020

Matthew O"Brien Maintained (ZBH) at Buy and Held Target at $160 on, Sep 21st, 2020


Published on 2024-10-27 13:32:24 - WOPRAI, Matthew O'Brien
  Print publication without navigation


Matthew O"Brien of Piper Sandler, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy and Held Target at $160 on, Sep 21st, 2020.

Matthew has made no other calls on ZBH in the last 4 months.

There are 6 other peers that have a rating on ZBH. Out of the 6 peers that are also analyzing ZBH, 0 agree with Matthew"s Rating of Hold.

These are the ratings of the 6 analyists that currently disagree with Matthew;

Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $155 on, Wednesday, August 5th, 2020
Lawrence Keusch of "Raymond James" Maintained at Strong Buy with Increased Target to $150 on, Wednesday, August 5th, 2020
Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $162 on, Wednesday, August 5th, 2020
Richard Newitter of "SVB Leerink" Maintained at Buy with Increased Target to $153 on, Wednesday, August 5th, 2020
David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Wednesday, August 5th, 2020
Jeff Johnson of "Baird" Maintained at Buy with Increased Target to $147 on, Wednesday, June 10th, 2020